PCOS telehealth · 2025

Best 5 PCOS telehealth brands — 2025

Historical snapshot from end-of-2025. Predates Knownwell's PCOS expansion and Pollie's phenotype protocol launch.
Other years:2026 →Methodology: 8-axis rubric →

Editorial reconstruction — not a live 2025 audit. These 2025 rankings were reconstructed editorially using available historical pricing, FDA filings, and review records. They are not pulled from a live quarterly audit performed in 2025. Treat as approximate. For the current ranking, see PCOS telehealth 2026 →

  1. Why: Multidisciplinary team — clear category leader.

    Best for: Insured patients seeking comprehensive PCOS care.

  2. Why: Physician founder with PCOS clinical depth.

    Best for: Women wanting BC + PCOS combined.

  3. Why: PCOS-only platform.

    Best for: Single-condition care preference.

  4. Why: New entrant focused on root-cause PCOS.

    Best for: Patients wanting alternative to Allara.

  5. Why: Hybrid model expanding to more clinic cities.

    Best for: Patients near Tia clinics.

Frequently asked

Why is multidisciplinary care prioritized for PCOS?

PCOS rarely presents as one issue — insulin resistance, mood changes, androgens, and fertility concerns typically coexist. Multidisciplinary teams (endo + nutrition + mental health) catch comorbidities general primary care misses.

What is phenotype-driven care?

PCOS has four recognized phenotypes (insulin-resistant, inflammatory, adrenal, post-pill). Treatment that matches phenotype outperforms one-size-fits-all metformin defaults in clinical outcomes.

Should I try inositol before metformin?

This is a clinical decision for your prescriber. Some evidence supports inositol as first-line for ovulatory dysfunction; others prefer metformin when insulin resistance is the primary driver. Discuss with and PCOS-trained clinician.

Other rankings

References

Professional society guidelines

  1. Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. View source ↗ (accessed 2026-06-01)
  2. Goodman NF, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review (PCOS guidelines). Endocr Pract. 2015;21(11):1291-1300. View source ↗ (accessed 2026-06-01)

Peer-reviewed research

  1. Unfer V, et al. Myo-inositol effects in women with PCOS: and meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658. View source ↗ (accessed 2026-06-01)

Was this Best PCOS telehealth ranking helpful?